
Growth Factors: Sold in creams for photoaging; evidence is specific to particular products. Peptides: Some specific peptide formulas modestly improve fine lines.


Consider only as an optional cosmetic; independent evidence is limited.
Consider for optional fine-line care; choose by the specific formula’s evidence.
Can you use both?
Both support repair and can be layered.
Compare uses by strength of evidence. Evidence level describes confidence in a benefit, not its size.









Signals can influence cells: Growth factors interact with specific receptors. Intact skin limits delivery: Large proteins may not reach deeper targets.
Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation. Some illustrated pathways are experimental; laboratory findings do not establish a clinical treatment benefit.

Some peptides signal to cells: Effects depend on the exact peptide sequence. Delivery and evidence vary: A peptide claim does not prove skin penetration.
Schematic illustration; not a measurement of skin penetration. Effects vary with ingredient identity and formulation. Some illustrated pathways are experimental; laboratory findings do not establish a clinical treatment benefit.
Built from where each one usually sits in a routine. Introduce one at a time.
Growth factors include different signaling proteins and mixtures. A percentage of conditioned media or a supplier complex does not specify the amount or activity of each growth factor.
Choosing a strength: Look for identification of the growth factors and clinical evidence for the exact finished formula.
Higher strengths: There is no established universal cosmetic percentage or proof that a higher blend percentage produces better results.
Formula matters: Early human studies of particular growth-factor preparations do not validate every growth-factor serum or delivery method.
Peptides are a family of different molecules, not one active ingredient with a shared percentage range. A supplier blend percentage may include water and other carriers.
Choosing a strength: Look for the peptide's exact name and a human study of the finished formulation.
Higher strengths: More peptide blend does not establish a larger dose of the named peptide or better results.
Formula matters: One facial-aging trial studied palmitoyl pentapeptide-4 at 3 parts per million. That amount cannot be generalized to other peptides or displayed as a universal peptide percentage.
Approximate windows, not promises.
First few weeksAssess tolerance and texture; immediate softness can come from the base formula.
First few weeksAssess tolerance and texture; immediate softness can come from the base formula.
4–8 weeksSubtle changes may appear in some tested products; evidence varies.
4–8 weeksSubtle changes may appear in some tested products; evidence varies.
8–12 weeksCompare photographs in the same lighting and reassess benefit.
8–12 weeksCompare photographs in the same lighting and reassess benefit.
3–6 monthsPhotoaging trials often need several months; expect modest rather than dramatic change.
3–6 monthsPhotoaging trials often need several months; expect modest rather than dramatic change.
6–12 monthsLong-term evidence is limited for many cosmetic actives; continue only if useful.
6–12 monthsLong-term evidence is limited for many cosmetic actives; continue only if useful.
May irritate; use only as directed on intact skin.
Usually comfortable in tested formulas; other ingredients may irritate.
Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.
Stop for persistent burning, swelling, blistering or a new rash. Seek urgent care for breathing difficulty or a severe allergic reaction.
Choose a simple formula and test a small area first. Individual tolerance matters more than an ingredient’s reputation for being gentle.
Choose a simple formula and test a small area first. Individual tolerance matters more than an ingredient’s reputation for being gentle.
Do not use a cosmetic product as a substitute for diagnosis of an unexplained, changing or persistent skin problem.
Do not use a cosmetic product as a substitute for diagnosis of an unexplained, changing or persistent skin problem.
Data are limited and these are usually paused in pregnancy; ask the clinician managing your pregnancy.
Data are limited; ask the clinician managing your pregnancy.
On the skin. The finished product delivers growth factors in a particular vehicle.
Entering skin. No single molecular mass. The 500 Da guideline cannot be applied to this whole ingredient family or mixture.
Conversion. No activation step is established as necessary for its intended topical role.
Skin response. Growth factors influence cell signalling, but passage of large proteins through intact skin is a delivery challenge.
Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.
On the skin. The finished product delivers peptides in a particular vehicle.
Entering skin. No single molecular mass. The 500 Da guideline cannot be applied to this whole ingredient family or mixture.
Conversion. No activation step is established as necessary for its intended topical role.
Skin response. Different peptides have different proposed signalling or conditioning effects; identity and delivery matter.
Additional effects. Proposed pathways do not establish a measured depth of delivery or clinical benefit beyond the studies cited.
Consider only as an optional cosmetic; independent evidence is limited.
An uncontrolled 14-person pilot tested eight growth factors together for 60 days. Without a vehicle control, it cannot separate the formula, natural variation and growth-factor effects.
Consider for optional fine-line care; choose by the specific formula’s evidence.
An industry-authored 93-woman controlled trial supports one palmitoyl pentapeptide formula over 12 weeks. It cannot validate every peptide or claims of Botox-like paralysis or lifting.
Sources